Praxis Precision Medicine...

NASDAQ: PRAX · Real-Time Price · USD
47.14
-0.56 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
47.08
-0.13%
After-hours: Aug 15, 2025, 04:34 PM EDT

Praxis Precision Medicines Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
157.41M 165.57M 215.37M 168.65M 145.14M 151.98M 81.3M 101.08M 124.3M 80.84M 61.62M 62.44M 56.04M 77.85M 138.7M 165.68M 175.88M 131.15M
Short-Term Investments
143.86M 162.42M 177.19M 188.39M 206.74M 55.44M n/a n/a n/a 4.98M 38.87M 61.3M 109.36M 144.66M 137.21M 148.69M 163.31M 139.66M
Long-Term Investments
145.37M n/a 76.96M 54.14M 82.37M 36.29M 416K 416K 416K 416K 416K 416K n/a n/a n/a 400K n/a n/a
Other Long-Term Assets
n/a 144.03M 416K 416K n/a n/a n/a n/a n/a n/a n/a n/a 416K 416K 472K 16K 496K 9K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
5.3M 5.58M 11.8M 3.02M 4.84M 4.39M 3.58M 2.24M 5.53M 8.58M 10.35M 8.57M 10.18M 11.96M 11.5M n/a n/a 7.75M
Total Current Assets
306.58M 333.57M 404.37M 360.05M 356.72M 211.8M 84.88M 103.33M 129.83M 94.4M 110.84M 132.31M 175.58M 234.47M 287.41M 319.34M 348.43M 278.56M
Property-Plant & Equipment
884K 1.13M 1.36M 1.65M 1.98M 2.32M 2.65M 2.98M 3.25M 3.56M 3.87M 4.17M 4.42M 4.62M 4.87M 4.65M 4.58M 680K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
146.25M 145.16M 78.74M 56.21M 84.35M 38.6M 3.07M 3.4M 3.67M 3.98M 4.29M 4.59M 4.84M 5.03M 5.34M 5.07M 5.08M 689K
Total Assets
452.83M 478.74M 483.11M 416.26M 441.06M 250.41M 87.95M 106.72M 133.5M 98.38M 115.13M 136.9M 180.42M 239.5M 292.75M 324.41M 353.51M 279.25M
Account Payables
28.83M 22.91M 12.53M 15.01M 8.2M 9.4M 5.82M 7.17M 8.01M 16.99M 14.67M 10.12M 11.82M 13.27M 10.78M 7.54M 7.4M 5.77M
Deferred Revenue
n/a n/a n/a 1.17M 1.18M 1.26M 1.39M 1.55M 2.04M 4.32M 5M n/a n/a n/a -3.5M n/a n/a n/a
Short-Term Debt
755K 1.07M n/a n/a 1.19M n/a 1.13M 1.09M 1.06M n/a n/a 977K 949K n/a n/a 681K 553K 578K
Other Current Liabilities
16.39M 15.55M 15.66M n/a 13.61M 5.32M 5.15M 7.73M 21.27M 7.6M 13.05M 14.26M 22.4M 28.59M 18.13M 10.62M 5.09M 5.53M
Total Current Liabilities
48.61M 39.52M 37.55M 32.86M 20.62M 18.79M 15.75M 16.79M 24.43M 30.66M 35.52M 28.98M 38.54M 45.22M 37.62M 24.75M 15.78M 13.74M
Long-Term Debt
n/a n/a n/a n/a n/a n/a 1.37M 1.66M 1.95M n/a n/a 2.76M 3.01M 3.26M n/a 3.73M 3.96M n/a
Other Long-Term Liabilities
n/a n/a n/a 293K n/a n/a -1.37M -1.66M -1.95M n/a n/a -2.76M -3.01M -3.26M n/a -3.73M -3.96M n/a
Total Long-Term Liabilities
n/a n/a 110K 729K 1.34M 1.93M 2.53M 3.18M 3.44M 3.26M 3.5M 2.76M 3.01M 3.26M 4.31M 3.73M 3.96M n/a
Total Liabilities
48.61M 39.52M 37.66M 33.59M 21.96M 20.73M 18.28M 19.97M 27.87M 33.91M 39.02M 31.74M 41.55M 48.48M 41.94M 28.49M 19.74M 13.74M
Total Debt
755K 1.07M 1.37M 1.66M 1.95M 2.22M 2.5M 2.76M 3.01M 3.26M 4.5M 3.73M 3.96M 4.28M 4.31M 4.41M 4.51M 578K
Common Stock
14K 14K 14K 14K 14K 13K 13K 13K 13K 6K 5K 5K 5K 5K 5K 5K 5K 4K
Retained Earnings
-977.16M -906.04M -836.74M -778.06M -726.15M -693.47M -653.92M -627.04M -602.41M -568.1M -530.64M -489.47M -445.53M -385.33M -316.62M -258.03M -213.33M -176.93M
Comprehensive Income
395K n/a 654K n/a -71K 3K n/a 0.00 -0.00 -19K -173K -536K -680K -606K -176K -25K -50K -86K
Shareholders Equity
404.22M 439.21M 445.45M 382.67M 419.1M 229.68M 69.67M 86.76M 105.63M 64.47M 76.11M 105.16M 138.87M 191.02M 250.81M 295.92M 333.77M 265.51M
Total Investments
289.23M 162.42M 254.16M 242.53M 289.1M 91.72M 416K 416K 416K 4.98M 38.87M 61.3M 109.36M 144.66M 137.21M 148.69M 163.31M 139.66M